Showing results (191-200 of 230) with videos related to
Sort By:
Pageof 23
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding riskM L Manzano, C Arocena, J F Tomás, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1994
Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin). An experimental investigation in healthy volunteersJ Holst, B Lindblad, D Bergqvist, et al.FEBS Letters|July 20, 1992
Generation of Gla-domainless FVIIa by cathepsin G-mediated cleavageE M Nicolaisen, L C Petersen, L Thim, et al.Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1975
Intravascular coagulation in pregnancy--treatment with heparinI M Nilsson, U Hedner, B Astedt, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1995
Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia AE Erhardtsen, M Ezban, M T Madsen, et al.Journal of Thrombosis and Haemostasis : JTH|December 1, 2010
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patientsH Agersø, D F Brophy, H Pelzer, et al.Thrombosis Research|September 15, 1989
Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH-NovoA Siegbahn, S Y-Hassan, J Boberg, et al.Thrombosis and Haemostasis|April 1, 1996
Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparinJ Holst, B Lindblad, S E Matthíasson, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 13, 2009
Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech RepublicP Salaj, P Brabec, M Penka, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Polymorphism of normal factor IX detected by mouse monoclonal antibodiesA Wallmark, R Ljung, I M Nilsson, et al.Pageof 23